ESTRO 2024

Session

Sunday

May 05

14:45 - 16:00

Armadillo

ESTRO-IASLC - Radiation dose in stage 3 NSCLC: To escalate or to de-escalate in IO/TKI era?

Chair: , The Netherlands;

Chair: Joe Chang, USA

Session Code: 2420

Session Type: Joint Symposium

Track: Clinical

14:45 - 15:03

The NARLAL II trial: First results on loco-regional control in stage 3 NSCLC

Speaker: Tine Schytte, Denmark

15:03 - 15:21

Rationale of dose de-escalation for stage 3 NSCLC

Speaker: , United Kingdom

15:21 - 15:39

Individualised dose-prescription for stage 3 NSCLC

Speaker: Nitin Ohri, USA

15:39 - 15:57

Risk-adapted and response-adapted strategies for stage 3 NSCLC

Speaker: , Italy